Urinary magnesium predicts risk of cardiovascular disease in Chronic Kidney Disease stage 1–4 patients
Qiongjing Yuan,Yanyun Xie,Zhangzhe Peng,Jinwei Wang,Qiaoling Zhou,Xiangcheng Xiao,Wei Wang,Ling Huang,Wenbin Tang,Xiaozhao Li,Luxia Zhang,Fang Wang,Ming-Hui Zhao,Lijian Tao,Kevin He,Siyi Wanggou,Hui Xu,C-STRIDE study group,Ming-Hui Zhao,Luxia Zhang,Xiaoqin Wang,Jun Yuan,Qiaoling Zhou,Qiongjing Yuan,Menghua Chen,Xiaoling Zhou,Shuxia Fu,Shaomei Li,Yan Zha,Rongsai Huang,Zhangsuo Liu,JunJun Zhang,Li Wang,Lei Pu,Jian Liu,Suhua Li,Zuying Xiong,Wei Liang,Jinghong Zhao,Jiao Mu,Xiyan Lian,Yunjuan Liao,Hua Gan,Liping Liao,Rong Wang,Zhimei Lv,Yunhua Liao,Ling Pan,Xiaoping Yang,Zhifeng Lin,Zongwu Tong,Yun Zhu,Qiang He,Fuquan Wu,Rong Li,Kai Rong,Caili Wang,Yanhui Zhang,Yue Wang,Wen Tang,Hua Wu,Ban Zhao,Rongshan Li,Lihua Wang,Detian Li,Feng Du,Yonggui Wu,Wei Zhang,Shan Lin,Pengcheng Xu,Hongli Lin,Zhao Hu,Fei Pei,Haisong Zhang,Yan Gao,Luying Sun,Xia Li,Wenke Wang,Fengling Lv,Deguang Wang,Xuerong Wang,Dongmei Xu,Lijun Tang,Yingchun Ma,Tingting Wang,Ping Fu,Tingli Wang,Changying Xing,Chengning Zhang,Xudong Xu,Haidong He,Xiaohui Liao,Shuqin Xie,Guicai Hu,Lan Huang
DOI: https://doi.org/10.1016/j.clnu.2020.10.036
IF: 7.643
2021-04-01
Clinical Nutrition
Abstract:Observational studies on dietary or circulating magnesium and risk of cardiovascular disease (CVD) in Chronic Kidney Disease (CKD) stage 1-4 have reported no-to-modest inverse associations. 24 h Urinary magnesium concentration (24 h UMg), an indicator of intestinal magnesium absorption, may provide better insight into the connection of CKD progression. We examined 3179 participants aged 18-74 years with CKD stage 1-4 in the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE) study, a prospective population-based cohort study. Data were analysed using Spearman rank-order correlation coefficients for all comparisons. We also performed a time-to-event analysis of the data using the Kaplan-Meier survival model, Cox proportional hazard model and competing risk Fine and Gray subdistribution hazard model. During a median follow-up of 4.19 years (interquartile range, 3.43-5.09 years), when modelling end-stage renal disease (ESRD), CVD and death, 24 h UMg was associated with risk of CVD (HR, 1.612 (95% CI, 1.056-2.460)), while no significant association with ESRD and death endpoints could be detected. 24 h UMg risk variants display a modest association with CVD in CKD stage 1-4 patients. TRIAL REGISTRATION: ClinicalTrials.gov Identifier NCT03041987. Registered January 1, 2012. (retrospectively registered) (https://www.clinicaltrials.gov/ct2/show/NCT03041987?term=Chinese+Cohort+Study+of+Chronic+Kidney+Disease+%28C-STRIDE%29&rank=1).
nutrition & dietetics